期刊文献+

社区人群C反应蛋白水平与高血压关系的前瞻性研究 被引量:6

The prospective study of association between C-reactive protein and hypertension in community population
原文传递
导出
摘要 目的 探讨基线血压正常人群的高敏C反应蛋白(hs-CRP)水平与随访期间高血压发病风险的关系.方法 以2000年4月“江苏省多代谢异常和代谢综合征综合防治研究”建立的队列人群为基础.在2006年6月开始对其中调查满5年者进行随访,共随访到2035名研究对象,测定其血中hs-CRP.将基线血压正常者按hs-CRP值进行四分位分组(<1.3、1.3~1.9、2.0 ~3.2和≥3.3 mg/L组,分别为514、498、515、508名),采用Cox风险比例回归模型分析不同水平hs-CRP、基线血压与高血压发病风险的关联.结果 2035名研究对象(男926名,女1109名)中位随访时间为6.39人年.hs-CRP<1.3、1.3~1.9、2.0~3.2和≥3.3 mg/L组的高血压的发病率分别为2378/10万人年、2942/10万人年、3693/10万人年、4390/10万人年.调整性别、年龄、基线血压、BMI、吸烟、饮酒、体力活动、心肌梗死和糖尿病家族史等因素后,与hs-CRP< 1.3 mg/L相比,hs-CRP为1.3~1.9、2.0~3.2和≥3.3 mg/L组的RR(95% CI)值分别为1.22(0.87~ 1.72)、1.43(1.03 ~2.00)和1.70(1.21~2.41).将基线血压四分位分层后,仍然发现各组的高血压发病率随着hs-CRP水平的增高而增高,在基线SBP<110 mm Hg(1 mm Hg=0.133 kPa)组,与hs-CRP<1.3 mg/L相比,hs-CRP为1.3~1.9、2.0~3.2和≥3.3 mg/L组的RR(95% CI)值分别为2.24(1.32 ~4.03)、2.57(1.57 ~4.57)、3.57(2.54 ~5.90);在基线DBP<65 mm Hg组,RR(95%CI)值分别为1.78(1.03~3.24)、2.74(1.63 ~4.93)、4.13(2.35 ~7.27).结论 炎症是高血压形成发展机制中的一个重要环节. Objective The aim was to explore the association between high-sensitivity C-reactive protein level at baseline and hypertension in follow-up periods in a Chinese cohort.Methods We analyzed data from a cohort established in "Prevention of metabolic syndrome and multi-metabolic disorders in Jiangsu province" in April 2000.A follow-up investigation was carried out for those whose follow up time met 5 years in June 2006.A total of 2035 persons completed investigation and hs-CRP was tested.Subjects with normal baseline blood pressure were classified into four groups (514,498,515 and 508 subjects in each group) according to quartiles of hs-CRP level (< 1.3,1.3-1.9,2.0-3.2 and ≥3.3 mg/L).The relationship between the risk of hypertension and baseline level of hs-CRP were analyzed using Cox proportional hazards regression model.Results The median of follow up time was 6.39 years among the 2035 subjects (926males and 1109 females).Hypertension incidence was 2378/100000 person-years,2942/100000 personyears,3693/100000 person-years and 4390/100000 person-years in hs-CRP < 1.3,1.3-1.9,2.0-3.2and ≥3.3 mg/L groups respectively.Compared to the group of hs-CRP < 1.3 mg/L,the relative risk (RR)(95% CI)of hypertension in groups of hs-CRP 1.3-1.9,2.0-3.2 and ≥3.3 mg/L was 1.22(0.87-1.72),1.43(1.03-2.00),1.70(1.21-2.41) respectively,adjusted for sex,age,baseline blood pressure,BMI,smoking,alcohol drinking,physical activitv and family history of myocardial infarction and diabetes.When stratified by quartiles of baseline blood pressure,the incidence of hypertension in each group increased with level of hs-CRP.In the group whose baseline SBP < 110 mm Hg(1 mm Hg =0.133 kPa),compared to the group of hs-CRP<1.3 mg/L,RR(95%CI) were 2.24(1.32-4.03),2.57(1.57-4.57) and 3.57 (2.54-5.90) in hs-CRP 1.3-1.9,2.0-3.2 and ≥ 3.3 mg/L groups respectively.In the group whose baseline DBP < 65 mm Hg,RR(95% CI) were 1.78 (1.03-3.24),2.74 (1.63-4.93) and 4.13 (2.35-7.27) respectively.Conclusion Inflammation was an important process in the development of hypertension.
出处 《中华预防医学杂志》 CAS CSCD 北大核心 2013年第11期1026-1030,共5页 Chinese Journal of Preventive Medicine
基金 卫生部科学研究基金(WKJ 2004-2-014)
关键词 高血压 C反应蛋白质 前瞻性研究 Hypertension C-reactive protein Prospective study
  • 相关文献

参考文献13

  • 1Kahn R,Buse J,Ferrannini E,et al.The metabolic syndrome:time tor a critical appraisal.Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.Diabetologia,2005,48 (9):1684-1699.
  • 2Ford ES,Giles WH.Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction:findings from National Health and Nutrition Examination Survey Ⅲ.J Clin Epidemiol,2000,53(1):95-102.
  • 3Bermudez EA,Rifai N,Buring J,et al.Inerrelationships among circulating interleukin-6,C-reactive protein,and traditional cardiovascular risk factors in women.Arterioscler Thromb Vasc Bion,2002,22 (10):1668-1673.
  • 4吴寿岭,王娜,赵海燕,刘义,朱峰,张子强,李金锋,金成,于青,李云.高敏C反应蛋白对高血压前期人群进展至高血压的预测价值[J].中华高血压杂志,2010,18(4):390-394. 被引量:57
  • 5Sesso HD,Buring JE,Rifai N,et al.C-reactive protein and the risk of developing hypertension.JAMA,2003,290 (22):2945-2951.
  • 6Gru mdv SM.Inflammation,hypertension,and the metabolic syndrome.JAMA,2003,290 (22):3000-3002.
  • 7Hall JE,Kuo JJ,da Silva AA,et al.Obesity-associated hypertension and kidney disease.Curr Opin Nephrol Hypertens,2003,12 (2):195-200.
  • 8Diehl AM,Nonalcoholic steatnsis and steatohepstitis Ⅳ.Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines.Am J Physiol Gastrointest Liver Physiol,2002,282(1):G1-G5.
  • 9Jialal I,Stein D,Balis D,et al.Effect of hydroxymethyl glutaryl coenzvme a reductase inhibitor therapy on high sensitive C-reactive protein levels.Circulation,2001,103 (15):1933-1935.
  • 10Verma S,Li SH,Badiwala MV,et al.Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein.Circulation,2002,105 (16):1890-1896.

二级参考文献15

  • 1Laaksonen DE, Niskanen L, Nyyssonen K, et al. C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study[J]. Eur Heart J,2005,26(17) :1783-1789.
  • 2Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 Report [J]. JAMA, 2003,289 (19) : 2560-2572.
  • 3De Marco M, de Simone G, Roman MJ, et al. Cardiovascular and metabolic predictors of progression of prebypertension into hypertension: the Strong Heart Study [J]. Hypertension, 2009,54 (5) :974-980.
  • 4Pitsavos C, Chrysohoou C, Panagiotakos DB, et al. Abdominal obesity and inflammation predicts hypertension among prehypertensive men and women: the ATTICA Study[J]. Heart Vessels, 2008,23(2) :96-103.
  • 5Wang TJ, Larson MG, Levy D, etal. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study[J]. Circulation, 2002,106 (10) :1189-1191.
  • 6Zhang YX, Cliff WJ, Schoefl GI, et al. Coronary C-reactive protein distribution: its relation to development of atherosclerosis[J]. Atherosclerosis, 1999,145(2) :375-379.
  • 7Di Napoli M, Papa F, Bocola Y, et al. C-reactive protein in ischemic stroke: an independent prognostic factor [J]. Stroke, 2001,32(4) : 917-924.
  • 8Ridker PM, Cushman M, Stampfer MJ, et al. Plasma concentration of c-reactive protein and risk of developing peripheral vascular disease[J]. Circulation, 1998,97(5) :425-428.
  • 9Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: collaborative analysis of date on 160309 participants from 54 cohorts[J]. Lancet. In press.
  • 10Zacho J, Tybjaerg-Hansen A, Jensen JS, et al. Genetically elevated C-reactive protein and ischemic vascular disease[J]. N Engl J Med,2008,359(18) :1897-1908.

共引文献56

同被引文献43

  • 1何江文.血清C反应蛋白在临床疾病诊断中的应用概况[J].医学信息(医学与计算机应用),2014(27):684-685. 被引量:2
  • 2张林峰,赵连成,周北凡,杨军,李莹,武阳丰.男性饮酒与缺血性脑卒中发病关系的研究[J].中华流行病学杂志,2004,25(11):954-957. 被引量:36
  • 3杨功焕,马杰民,刘娜,周灵妮.中国人群2002年吸烟和被动吸烟的现状调查[J].中华流行病学杂志,2005,26(2):77-83. 被引量:1056
  • 4Wamakulasuriya S. Global epidemiology of oral andoropharyngeal cancer[J]. Oral Oncol, 2009, 45(4-5): 309-316.
  • 5Schmidt BL, Dierks EJ, Homer L, et al. Tobacco smokinghistory and presentation of oral squamous cell carcinoma[J]. JOral Maxillofac Surg, 2004, 62(9):1055-1058.
  • 6Albuquerque R, Lopez-L6pez J, Mari-Roig A, et al. Oraltongue squamous cell carcinoma (OTSCC): alcohol andtobacco consumption versus non-consumption. A study in aPortuguese population[J]. Braz Dent J, 2011, 22(6): 517-521.
  • 7Meurman JH. Infectious and dietary risk factors of oral cancer[J]. Oral Oncol, 2010,46(6): 411-413.
  • 8Tseng CH. Oral cancer in Taiwan: is diabetes a risk factor.[J]. Clin Oral Investig, 2013,17(5): 1357-1364.
  • 9Rado'i L, Paget-Bailly S, Menvielle G,et al. Tea and coffeeconsumption and risk of oral cavity cancer: Results of a largepopulation-based case-control study, the ICARE study[J].Cancer Epidemiol,2013, 37(3):284-289.
  • 10Alnuaimi AD, Wiesenfeld D, O'Brien-Simpson NM, et al.Oral Candida colonization in oral cancer patients and itsrelationship with traditional risk factors of oral cancer: Amatched case-control study[J]. Oral Oncol, 2015, 51(2):139-145.

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部